Skip to main content
    I

    Insmed Inc (INSM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $121.86
    -1.02 (-0.83%)

    Market Cap: $26.96B

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Insmed Inc (INSM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Insmed (INSM) has a market cap of $26.96B and an enterprise value of $27.12B. Revenue grew 239.97% over the last 12 months from the 12 months before. It kept -39.85% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 0.59% above the market cap, as debt exceeds cash.

    Market Cap$26.96B
    Enterprise Value$27.12B
    Latest price (Nov 17, 2026)$121.86

    Key Dates

    The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 17, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.66% in the quarter ended Sep 30, 2026 and grew 12.22% a year over 2 years.

    Shares Outstanding218.79M
    Shares Change (YoY)+3.32%
    Shares Change (QoQ)+0.66%
    Share Count Growth (2Y CAGR)+12.22%

    Valuation Ratios

    Sales and book value multiples are 17.5x and 36.7x. Its year-end P/S ranged from 10.0x to 102.8x from 2018 to 2025.

    P/S Ratio17.5x
    Forward P/S14.5x
    P/B Ratio36.7x
    P/TBV Ratio59.0x

    Valuation history and multiples

    Price Statistics

    The stock is down 36.93% over 52 weeks and trades 10.09% above its 50-day average.

    Beta (1Y)0.55
    52-Week Change-36.93%
    1-Month Change+27.88%
    3-Month Change-6.74%
    6-Month Change+13.45%
    5-Year Change+273.40%
    10-Year Change+767.33%
    Total Return (1Y)-36.93%
    Total Return (3Y CAGR)+69.94%
    Total Return (5Y CAGR)+31.85%
    Return vs SPY (1Y)-51.12%
    Max Drawdown (1Y)-56.54%
    Max Drawdown (3Y)-56.54%
    Sharpe Ratio (1Y)-0.82
    Correlation with SPY (1Y)0.12
    50-Day Average$110.69
    200-Day Average$122.83
    52-Week Range$90.39 to $212.75
    RSI (14 Days)64.7
    Average Volume (20 Days)3.74M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.86x current liabilities, and total debt is 0.76x shareholder equity.

    Current Ratio2.86x
    Quick Ratio2.59x
    Debt / Equity0.76x
    Interest Coverage-6.96x

    Returns and Efficiency

    Return on invested capital is -44.18% over the last 12 months, against a 5-year average of -97.55%.

    Return on Equity (ROE)-83.39%
    Return on Assets (ROA)-27.21%
    Return on Invested Capital (ROIC)-44.18%
    Return on Capital Employed (ROCE)-34.74%
    ROA (5Y Average)-44.38%
    ROIC (5Y Average)-97.55%
    Asset Turnover0.66x
    Inventory Turnover1.55x
    Receivables Turnover6.40x
    Cash Conversion Cycle-480 days

    Scores

    INSM has an Altman Z-Score of 7.39, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score7.39
    Altman Z ZoneSafe
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $1.52B over the last 12 months.

    Revenue$1.52B
    Revenue Growth (YoY)+239.97%
    Gross Profit$1.28B
    Operating Income-$563.99M
    Pretax Income-$598.06M
    Net Income-$605.61M
    EBITDA-$533.41M
    EBIT-$566.02M
    Reported EPS (TTM)-$3.28

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 32.57% of the $2.23B in total assets.

    Cash and Equivalents$396.56M
    Total Debt$555.09M
    Net Debt$158.53M
    Net Debt Per Share$0.72
    Working Capital$1.11B
    Shareholder Equity$726.21M
    Book Value Per Share$3.32
    Tangible Book Value$451.67M
    Tangible Book Per Share$2.06
    Total Assets$2.23B
    Total Liabilities$1.50B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $31.95M of capital spending, operating cash flow left -$627.58M of free cash flow.

    Operating Cash Flow-$595.62M
    Capital Expenditures$31.95M
    Free Cash Flow-$627.58M
    FCF Per Share-$2.87
    Depreciation and Amortization$32.61M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -37.11%.

    Gross Margin84.40%
    Operating Margin-37.11%
    Pretax Margin-39.35%
    Net Margin-39.85%
    EBITDA Margin-35.10%
    EBIT Margin-37.24%
    FCF Margin-41.30%
    Gross Margin (5Y Average)77.75%

    Growth

    Revenue grew 35.20% a year over 3 years.

    Revenue Growth (3Y CAGR)+35.20%
    Revenue Growth (5Y CAGR)+29.83%

    Revenue and profit by year

    Dividends and Yields

    INSM does not pay a dividend. Its free cash flow yield is -2.35%.

    FCF Yield-2.35%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-10 reverse split on Mar 3, 2011.

    Last Split DateMar 3, 2011
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 10 similar companies, INSM has the 5th highest P/S.

    P/S Ratio17.5x vs 14.7x median
    ROIC-44.18% vs 4.83% median
    Revenue Growth (Trailing 4 Quarters, YoY)+239.97% vs +13.48% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 122.14% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+122.14%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INSM

    What is INSM's market cap?

    Insmed has a market cap of $26.96B. Its enterprise value, which adds debt and subtracts cash, is $27.12B.

    How many shares of INSM are outstanding?

    Insmed has 218.79M shares outstanding. The count is up 3.32% from a year earlier.

    Does INSM pay a dividend?

    No. Insmed does not pay a dividend.

    How much debt does INSM have?

    Insmed has $555.09M of total debt and $396.56M of cash and equivalents, a net debt position of $158.53M.